Paulline Paiva Mendes de Souza Leal

Paulline Paiva Mendes de Souza Leal

Auto-generated profile, based on publicly available information

Paulline Paiva Mendes de Souza Leal

Graduate Program in Technologies Applied to Animals of Regional Interest, Federal University of Piauí, Teresina, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PNPastora P. Lima Neta
Pastora P. Lima Neta
PLPaulline P.M.S. Leal
Paulline P.M.S. Leal
VPVictória Hannah A.A. Passos
Victória Hannah A.A. Passos
FCFrancisco DAS Chagas DE S. Cunha
Francisco DAS Chagas DE S. Cunha
BABianca S. DOS Anjos
Bianca S. DOS Anjos
MAMichel M.M. Alves
Michel M.M. Alves
Leishmaniasis is a group of diseases caused by protozoa of the genus Leishmania. Current treatments exhibit high toxicity, high costs, and parasite resistance. Consequently, the search for new drugs is of utmost importance, and drug repositioning may offer an alternative for combating the disease. This study aimed to evaluate the antileishmanial and cytotoxic activities, as well as macrophage activation parameters, of oseltamivir (OSV) and acyclovir (ACV). The substances demonstrated antileishmanial activity. The median inhibitory concentration (IC50) values of OSV against different species (L. amazonensis, L. braziliensis, L. infantum, and L. major) were 252.321, 268.161, 29.207, and 143.859 μg/mL, respectively. For ACV, the IC50 values were 25.726, 45.552, 580.741, and 608.981 μg/mL, respectively. The median cytotoxic concentrations (CC50) of OSV and ACV were 512.17 and 2568.75 μg/mL, respectively. Both OSV and ACV significantly reduced the percentage of infected macrophages, with a selectivity index (SI) >20. Additionally, OSV and ACV increased phagocytic capacity but did not enhance lysosomal activity or significantly induce nitric oxide synthesis. Further investigations are necessary to evaluate these substances in experimental in vivo infection models.

8 January 2026 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
RSRosilene Ribeiro de Sousa
Rosilene Ribeiro de Sousa
MNMatheus Oliveira Do Nascimento
Matheus Oliveira Do Nascimento
LSLeandro Josual da Costa Santos
Leandro Josual da Costa Santos
FAFrancisco Gesley de Sousa Abreu
Francisco Gesley de Sousa Abreu
AMAndré Luiz Pinheiro de Moura
André Luiz Pinheiro de Moura
ACAndré Carvalho
André Carvalho

23 January 2026 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
RSRosilene Ribeiro de Sousa
Rosilene Ribeiro de Sousa
MNMatheus Oliveira Do Nascimento
Matheus Oliveira Do Nascimento
LSLeandro Josual da Costa Santos
Leandro Josual da Costa Santos
FAFrancisco Gesley de Sousa Abreu
Francisco Gesley de Sousa Abreu
AMAndré Luiz Pinheiro de Moura
André Luiz Pinheiro de Moura
ACAndré Carvalho
André Carvalho